News about

IPC adds 9 new IP impurities standards

IPC adds 9 new IP impurities standards

The Indian Pharmacopoeia Commission (IPC) has added 9 new IP impurities standards which includes Bromhexine Hydrochloride Impurity C, Cabergoline Impurity A, Cilostazol Impurity B, Citalopram Impurity B, Fosinopril Impurity A, o-toluene sulfonamide, p-toluene sulfonamide, Tributyl o-acetyl citrate/Acetyl Tributyl citrate, Vildagliptin Impurity D

| 07/12/2021 | By 1061

NPPA fixes retail price of 20 new drugs

NPPA fixes retail price of 20 new drugs

The National Pharmaceutical Pricing Authority (NPPA) has announced retail price fixation of 20 new drugs based on the decision of its Authority meeting held on November 15, 2021. Out of the total new drugs for which the prices were fixed, 17 were combinations containing diabetes drug Dapagliflozin, which was patented by drug major AstraZeneca

| 07/12/2021 | By 333

Lupin enters into distribution and marketing agreement with Biomm

Lupin enters into distribution and marketing agreement with Biomm

Global pharma major, Lupin Limited announced that they have entered into an distribution and marketing agreement with Biomm SA in Brazil

| 07/12/2021 | By 404

Synapsica partners with GenWorks Health for AI enabled PACS radiology workflow solution Radiolens

Synapsica partners with GenWorks Health for AI enabled PACS radiology workflow solution Radiolens

Synapsica, India's leading AI-based radiology reporting company has partnered with Wipro GE backed GenWorks Health, a leading healthcare solutions provider to promote and distribute the former's AI enabled PACS (Picture Archiving and Communication System) radiology workflow solution Radiolens across the country

| 06/12/2021 | By 522

Future of pharma companies communication with doctors would be hybrid model: Survey

Future of pharma companies communication with doctors would be hybrid model: Survey

The future of pharmaceutical companies? communication with doctors would be a hybrid model of digital communication supported by physical connect, as almost 40 per cent of the doctors prefer the model, according to a recent survey on the trends in pharma communication post Covid-19 pandemic by Rediffusion Healthcare.

| 30/11/2021 | By 1066

GE Healthcare, Optellum collaborate to advance lung cancer diagnosis with artificial intelligence

GE Healthcare, Optellum collaborate to advance lung cancer diagnosis with artificial intelligence

GE Healthcare, a leading global medical technology, pharmaceutical diagnostics and digital solutions innovator, and Optellum, a commercial-stage lung health company, have signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer

| 29/11/2021 | By 272

Biotron announces its lead clinical asset, BIT225 effective against SARS-CoV-2 in animal and cell-based studies

Biotron announces its lead clinical asset, BIT225 effective against SARS-CoV-2 in animal and cell-based studies

Biotron Limited, a company engaged in the research, development, and commercialisation of drugs targeting significant viral diseases with unmet medical need, announced that the company?s lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against SARS-CoV-2 in a series of animal and cell-based studies performed

| 29/11/2021 | By 247

Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi

Encube Ethicals to acquire Soframycin for India and Sri Lanka markets from Sanofi

Encube Ethicals has agreed to enter into definitive agreements with Sanofi group and its affiliates, including Sanofi India for acquiring some of its brands ? Soframycin, along with other legacy-associated brands Sofradex, Sofracort, Soframycin-Tulle for India and Sri Lanka markets, a statement from Encube notified

| 27/11/2021 | By 447

CPhI partners with Informa Pharma Intelligence to present 2021 hybrid edition of CPhI and P-Mec Expo in NCR

CPhI partners with Informa Pharma Intelligence to present 2021 hybrid edition of CPhI and P-Mec Expo in NCR

Informa Pharma Intelligence announced the 2021 hybrid edition of CPhI and P-Mec conducted by CPhI Conference. The online conference and networking is being held between 15th and 30th Nov 2021, while the in-person event was held between 24th and 26th November, 2021 at India Expo Centre? Greater Noida, according to a statement by Informa

| 27/11/2021 | By 193

MSRVantage to provide AI-based blockchain solution to weed out counterfeit products in pharma

MSRVantage to provide AI-based blockchain solution to weed out counterfeit products in pharma

MSRCosmos, a US-based software solutions provider, has set up a new start-up MSRVantage in Hyderabad to provide AI enabled blockchain solutions for pharma, biotech, healthcare and various other allied product manufacturing industries

| 26/11/2021 | By 333

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members